Acta Paediatrica 1996-03-01

Treatment of pituitary resistance to thyroid hormone (PRTH) in an 8-year-old boy.

J Pohlenz, D Knöbl

Index: Acta Paediatr. 85(3) , 387-90, (1996)

Full Text: HTML

Abstract

We report on an 8-year-old boy with pituitary resistance to thyroid hormone (PRTH) having a cysteine for arginine substitution at codon 320 in the TR-beta gene who was presented because of thyrotoxicosis. Due to its suppressive effect on the pituitary thyrotropin secretion, treatment with D-thyroxine (D-T4) was started. After a few days, clinical euthyroidism was achieved but thyroid stimulating hormone secretion was not suppressed. Symptoms of thyrotoxicosis relapsed when therapy was interrupted so that therapy with D-T4 was reinstituted and continued to date. Symptoms did not recur, and the psychomotor development proceeded normally. D-T4 should therefore be considered in the treatment of thyrotoxicosis in PRTH.


Related Compounds

Related Articles:

Design of mechanism-based inhibitors of transthyretin amyloidosis: studies with biphenyl ethers and new structural templates.

2007-11-15

[J. Med. Chem. 50 , 5589-99, (2007)]

Maintenance of brain thyroid hormone level during peripheral hypothyroid condition in adult rat.

2006-09-05

[Life Sci. 79(15) , 1450-5, (2006)]

Dextrothyroxine in the treatment of generalized thyroid hormone resistance in a boy homozygous for a defect in the T3 receptor.

1992-04-01

[Thyroid 2(1) , 15-9, (1992)]

A novel resistance to thyroid hormone associated with a new mutation (T329N) in the thyroid hormone receptor beta gene.

1999-02-01

[Thyroid 9(2) , 165-71, (1999)]

Effect of L-thyroxine (LT4) and D-thyroxine (DT4) on cardiac function and high-energy phosphate metabolism: a 31P NMR study.

1991-03-01

[Magn. Reson. Med. 18(1) , 237-43, (1991)]

More Articles...